Prognostic and Therapeutic Value of LSM5 Gene in Human Brain Cancer Glioma: An Omics Database Exploration Approach
preprint
OA: closed
CC-BY-4.0
Abstract
• This study explored the clinical relevance of LSM5 gene in glioma diagnosis and treatment for the first time • LSM5 is overexpressed in lower-grade glioma (LGG) and glioblastoma multiforme (GBM) tissues • The promoter of LSM5 gene is differentially methylated in both LGG and GBM tissues • The expression of LSM5 correlates with the survival condition and immunophenotypes of glioma patients
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-4.0